Bromocriptine in parkinsonism

British Medical Journal

Volumn 4, Issue 5942, 1974, Pages 442-444

  Calne, D B ^a   Teychenne, P F ^a   Claveria, L E ^a   Eastman, R ^a   Greenacre, J K ^a   Petrie, A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CAFFEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; DOPAMINE; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; LEVODOPA; PHOSPHODIESTERASE INHIBITOR; PLACEBO;

ADVERSE DRUG REACTION; BLOOD PRESSURE; BODY POSTURE; CEREBROSPINAL FLUID; CLINICAL STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG RESPONSE; DRUG THERAPY; HEART RATE; HYPERSALIVATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PARKINSONISM; RIGIDITY; SPEECH; SWEATING; THERAPY; TREMOR; WALKING;

AGED; BLOOD PRESSURE; BROMINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOT ALKALOIDS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PULSE; RECEPTORS, DRUG;

EID: 0016265338     PISSN: 00071447     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.4.5942.442     Document Type: Article

References (9)

1. Corrodi, H., et al. (1973). Journal of Pharmacy and Pharmacology, 25, 409.
2. Cotzias, G. C., et al. (1970). New England Journal of Medicine, 282, 31.
3. Farnebo, L. O., and Hamberger, B. (1973). In Frontiers in Catecholamine Research, ed. S. H. Snyder, and E. Usdin. New York, Pergamon Press.
4. Kebabian, J. W., Petzold, G. L., and Greengard, P. (1972). Proceedings of the National Academy of Sciences of the U.S.A., 69, 2145.
5. Lloyd, K. G., and Hornykiewicz, O. (1970). Science, 170, 1212.
6. Pozo, E. del, and Flückiger, E. (1973). In Human Prolactin, ed. J. L. Pasteels and C. Robyn. Amsterdam, Excerpta Medica.
7. Vakil, S. D., et al. (1973). In Progress in the Treatment of Parkinsonism, Advances in Neurology, Vol. 3., ed. D. B. Calne, p. 121. New York, Raven Press.
8. Walters, J. R., Bunney, B. S., and Roth, R. H. (1974). In Dopaminergic Mechanisms, Advances in Neurology, vol. 5, ed. D. B. Calne, T. N. Chase, and A. Barbeau. New York, Raven Press.
9. Yahr, M. D. (editor) (1973). The Treatment of Parkinsonism—The Role of Dopa Decarboxylase Inhibitors, Advances in Neurology, vol. 2. New York, Raven Press.